[go: up one dir, main page]

PT3490526T - Solução aquosa cristaloide isotónica - Google Patents

Solução aquosa cristaloide isotónica

Info

Publication number
PT3490526T
PT3490526T PT177403987T PT17740398T PT3490526T PT 3490526 T PT3490526 T PT 3490526T PT 177403987 T PT177403987 T PT 177403987T PT 17740398 T PT17740398 T PT 17740398T PT 3490526 T PT3490526 T PT 3490526T
Authority
PT
Portugal
Prior art keywords
crystallous
isotonic
water solution
solution
water
Prior art date
Application number
PT177403987T
Other languages
English (en)
Original Assignee
Oller Duque Lara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59363165&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3490526(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oller Duque Lara filed Critical Oller Duque Lara
Publication of PT3490526T publication Critical patent/PT3490526T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/20Elemental chlorine; Inorganic compounds releasing chlorine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/241Lead; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/242Gold; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT177403987T 2016-07-26 2017-07-18 Solução aquosa cristaloide isotónica PT3490526T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201631021A ES2651717B1 (es) 2016-07-26 2016-07-26 Solución acuosa cristaloide isotónica

Publications (1)

Publication Number Publication Date
PT3490526T true PT3490526T (pt) 2020-08-21

Family

ID=59363165

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177403987T PT3490526T (pt) 2016-07-26 2017-07-18 Solução aquosa cristaloide isotónica

Country Status (17)

Country Link
US (1) US11426427B2 (pt)
EP (1) EP3490526B1 (pt)
JP (1) JP6976326B2 (pt)
KR (1) KR102404536B1 (pt)
CN (1) CN109789087B (pt)
AU (1) AU2017304376A1 (pt)
BR (1) BR112019001621A2 (pt)
CA (1) CA3031845A1 (pt)
DK (1) DK3490526T3 (pt)
ES (2) ES2651717B1 (pt)
HU (1) HUE051026T2 (pt)
MX (1) MX378378B (pt)
PL (1) PL3490526T3 (pt)
PT (1) PT3490526T (pt)
RU (1) RU2739561C2 (pt)
WO (1) WO2018019663A1 (pt)
ZA (1) ZA201900542B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
CA3128232A1 (en) * 2019-02-01 2020-08-06 Thermolife International, Llc Enhanced nitrate compositions and methods of use
US12156886B2 (en) 2020-11-12 2024-12-03 Thermolife International, Llc Methods of increasing blood oxygen saturation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
JP3715312B2 (ja) * 1993-06-04 2005-11-09 バイオタイム インク 血漿様溶液
US6940827B2 (en) * 2001-03-09 2005-09-06 Adaptix, Inc. Communication system using OFDM for one direction and DSSS for another direction
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
KR100478982B1 (ko) 2002-05-02 2005-03-25 금호석유화학 주식회사 신규 산발생제 및 이를 함유한 박막 조성물
US7498039B2 (en) * 2002-10-10 2009-03-03 Thompson Diana F Nutritional supplement containing sea water minerals
EP1648475B1 (en) 2003-07-09 2007-09-12 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7759306B2 (en) * 2006-05-16 2010-07-20 Simoni Jan S Methods of treating acute blood loss
EP2543249B1 (en) 2007-02-17 2018-05-23 President and Fellows of Harvard College Compositions and method for tissue preservation
US20090209550A1 (en) 2008-02-20 2009-08-20 Auspex Pharmaceuticals, Inc. Substituted triazolopyridines
ES2343777B1 (es) 2009-01-14 2011-05-25 Laboratoires Quinton International S.L Procedimiento de recogida y envasado farmaceutico de agua de mar.
DE102009034132A1 (de) * 2009-07-20 2011-01-27 B. Braun Melsungen Ag Plasmaadaptierte und balancierte Gelatinelösung
RU2423987C1 (ru) * 2009-12-31 2011-07-20 Государственное образовательное учреждение высшего профессионального образования САНКТ-ПЕТЕРБУРГСКАЯ ГОСУДАРСТВЕННАЯ ХИМИКО-ФАРМАЦЕВТИЧЕСКАЯ АКАДЕМИЯ Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО СПХФА Росздрава) Инфузионный раствор для восполнения объема циркулирующей крови, восстановления водно-электролитного баланса и нормализации процессов кроветворения
EP2717879B1 (en) * 2011-06-10 2017-08-16 Queen Mary University of London Artemisinin and derivatives for use in the treatment of trauma haemorrhage
JP2015508101A (ja) * 2012-02-21 2015-03-16 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated Cd34+細胞を含む薬学的組成物
CN103989704A (zh) * 2013-02-19 2014-08-20 B.布劳恩梅尔松根股份公司 用于输液的电解质水溶液
KR102236226B1 (ko) * 2013-05-08 2021-04-02 감브로 룬디아 아베 투석 제제

Also Published As

Publication number Publication date
AU2017304376A1 (en) 2019-02-14
US11426427B2 (en) 2022-08-30
ES2651717B1 (es) 2018-11-16
CA3031845A1 (en) 2018-02-01
PL3490526T3 (pl) 2021-03-08
RU2019102162A3 (pt) 2020-08-26
ES2811354T3 (es) 2021-03-11
DK3490526T3 (da) 2020-08-17
HUE051026T2 (hu) 2021-03-01
CN109789087B (zh) 2022-12-20
KR20190039156A (ko) 2019-04-10
KR102404536B1 (ko) 2022-05-31
JP2019522060A (ja) 2019-08-08
RU2739561C2 (ru) 2020-12-25
JP6976326B2 (ja) 2021-12-08
US20210308179A1 (en) 2021-10-07
EP3490526B1 (en) 2020-05-13
EP3490526A1 (en) 2019-06-05
BR112019001621A2 (pt) 2019-04-30
ZA201900542B (en) 2022-08-31
WO2018019663A1 (en) 2018-02-01
ES2651717A1 (es) 2018-01-29
CN109789087A (zh) 2019-05-21
MX378378B (es) 2025-03-10
MX2019001077A (es) 2019-08-29
RU2019102162A (ru) 2020-08-26

Similar Documents

Publication Publication Date Title
NO2025005I1 (no) Palopegteriparatide
DK3137587T3 (da) Detergentsammensætning
EP3540346A4 (en) WATER PURIFIER
FI20160137A (fi) Vikavirtaindikaattori
EP3435660A4 (en) HEAD-MOUNTED DISPLAY
EP3484035A4 (en) HYSTERESIS SUPPLY CIRCUIT
BR112017013841A2 (pt) solução oftálmica aquosa
FI20155351A (fi) Vedenpuhdistus
EP3402021A4 (en) GRAB WIRE
DK3509963T3 (da) Pallecontainer
EP3495770A4 (en) Stereo camera
FI20155350A (fi) Vedenpuhdistus
EP3425626A4 (en) REED
EP3552682C0 (en) WATER PURIFIER
DE112017006386A5 (de) Schraubarbeitszylinder
DE112017000734A5 (de) Glycolsensor
DK3325728T3 (da) Spildevandsbrønd
PT3490526T (pt) Solução aquosa cristaloide isotónica
DE112017005767A5 (de) Nasslaufende lamellenkupplung
ME03734B (me) KOMBINACIJA KANRENOATA I Ei<SENATIDA
ES1159683Y (es) Protesis neovaginal
DK3476320T3 (da) Intramedullær fikseringsanordning
DE112017006474A5 (de) Gargerätevorrichtung
DE112017000296A5 (de) Radgeschwindigkeitssensorvorrichtung
DE102016001934A8 (de) Verdunster